Medical University of South Carolina

About: Medical University of South Carolina is a education organization based out in Charleston, South Carolina, United States. It is known for research contribution in the topics: Population & Poison control. The organization has 23436 authors who have published 45440 publications receiving 1769397 citations. The organization is also known as: MUSC & Medical College of the State of South Carolina.

Diagnosis and Detection of Sarcoidosis An Official American Thoracic Society Clinical Practice Guideline

Abstract: Background: The diagnosis of sarcoidosis is not standardized but is based on three major criteria: a compatible clinical presentation, finding nonnecrotizing granulomatous inflammation in one or mo...

Ten year revision of the brief behavioral activation treatment for depression: revised treatment manual.

Abstract: Following from the seminal work of Ferster, Lewinsohn, and Jacobson, as well as theory and research on the Matching Law, Lejuez, Hopko, LePage, Hopko, and McNeil developed a reinforcement-based depression treatment that was brief, uncomplicated, and tied closely to behavioral theory. They called this treatment the brief behavioral activation treatment for depression (BATD), and the original manual was published in this journal. The current manuscript is a revised manual (BATD-R), reflecting key modifications that simplify and clarify key treatment elements, procedures, and treatment forms. Specific modifications include (a) greater emphasis on treatment rationale, including therapeutic alliance; (b) greater clarity regarding life areas, values, and activities; (c) simplified (and fewer) treatment forms; (d) enhanced procedural details, including troubleshooting and concept reviews; and (e) availability of a modified Daily Monitoring Form to accommodate low literacy patients. Following the presentation of the manual, the authors conclude with a discussion of the key barriers in greater depth, including strategies for addressing these barriers.

Aspirin therapy in diabetes.

Abstract: People with diabetes have a twoto fourfold increase in the risk of dying from the complications of cardiovascular disease (1). Atherosclerosis and vascular thrombosis are major contributors. In type 2 diabetes, the increased risk is present before fasting hyperglycemia is seen. These individuals often have a sedentary lifestyle, poor physical conditioning, insulin resistance, centripetal obesity, hypertension, and dyslipidemia, and are in a prothrombotic state. Chronic hyperglycemia is then added to these risk markers. Microalbuminuria may precede hyperglycemia in type 2 diabetes, occurs in 30-40% of those individuals after diabetes is established, and is a predictor of cardiovascular events. In type 1 diabetes, microalbuminuria is a predictor of renal failure and cardiovascular events. An all-inclusive approach that focuses on early risk factor (or marker) identification and management to prevent or delay accelerated atherosclerosis and thrombosis in diabetes is an attractive strategy (2).